Journal
ANTIBIOTICS-BASEL
Volume 12, Issue 5, Pages -Publisher
MDPI
DOI: 10.3390/antibiotics12050861
Keywords
antibiofilm activity; antifungal synergism; fluopsin C; green silver nanoparticles; indolin-3-one
Categories
Ask authors/readers for more resources
Candida auris is a drug-resistant fungal pathogen that causes potentially fatal infections in humans. This study found that the metabolites of Pseudomonas aeruginosa LV strain, combined with biologically synthesized silver nanoparticles, showed synergistic fungicidal activity against C. auris, leading to changes in fungal morphology and ultrastructure. These findings suggest a new strategy for controlling C. auris infections.
Candida auris has been found to be a persistent colonizer of human skin and a successful pathogen capable of causing potentially fatal infection, especially in immunocompromised individuals. This fungal species is usually resistant to most antifungal agents and has the ability to form biofilms on different surfaces, representing a significant therapeutic challenge. Herein, the effect of metabolites of Pseudomonas aeruginosa LV strain, alone and combined with biologically synthesized silver nanoparticles (bioAgNP), was evaluated in planktonic and sessile (biofilm) cells of C. auris. First, the minimal inhibitory and fungicidal concentration values of 3.12 and 6.25 mu g/mL, respectively, were determined for F4a, a semi-purified bacterial fraction. Fluopsin C and indolin-3-one seem to be the active components of F4a. Like the semi-purified fraction, they showed a time- and dose-dependent fungicidal activity. F4a and bioAgNP caused severe changes in the morphology and ultrastructure of fungal cells. F4a and indolin-3-one combined with bioAgNP exhibited synergistic fungicidal activity against planktonic cells. F4a, alone or combined with bioAgNP, also caused a significant decrease in the number of viable cells within the biofilms. No cytotoxicity to mammalian cells was detected for bacterial metabolites combined with bioAgNP at synergistic concentrations that presented antifungal activity. These results indicate the potential of F4a combined with bioAgNP as a new strategy for controlling C. auris infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available